Theriva Biologics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -708.8% | -708.8% | -121.1% |
| FY2017 | 1,014.3% | 1,014.3% | -80.5% |
| FY2018 | -78.3% | -78.3% | -44.3% |
| FY2019 | -840.4% | -840.4% | -88.8% |
| FY2020 | 210.7% | 210.7% | -119.4% |
| FY2021 | -21.8% | -21.8% | -20.3% |
| FY2022 | -38.0% | -37.8% | -27.4% |
| FY2023 | -49.6% | -49.4% | -33.2% |
| FY2024 | -134.5% | -133.9% | -72.6% |
| FY2025 | -154.3% | -139.2% | -62.1% |